the Pulmonary Safety of Antihepatitis C Treatment
NCT04122066
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
sofosbuvir \daclatsvir
Sponsor
Assiut University